Diseases, Conditions, Syndromes

Late mortality down for blood or marrow transplant recipients

(HealthDay)—Allogeneic blood or marrow transplantation (BMT) recipients have experienced a reduction in late mortality over time, according to a study published online Sept. 9 in JAMA Oncology.

Other

Sanofi buys US biotech firm in acquisition spree

French pharmaceutical giant Sanofi announced on Wednesday its second acquisition of a US firm in as many months, buying transplant drug company Kadmon for $1.9 billion (1.6 billion euros).

Oncology & Cancer

Genomic markers of aggressive childhood leukemias identified

New research published today in JAMA Oncology reports how two separate DNA changes appear to predict aggressive childhood leukemias when they occur in combination. Over the course of a decade of work in several study sites ...

Surgery

Mayo Clinic: Why bone marrow donor diversity is needed

Bone marrow transplants are procedures that infuse healthy blood stem cells into your body to replace damaged or diseased bone marrow. Just like people in need of solid organ transplants, such as hearts or kidneys, people ...

Medical research

Genetic factors linked to response to common antiviral medications

St. Jude Children's Research Hospital scientists and collaborators in Sweden and Japan are reporting that the enzyme NUDT15 plays a role in how patients respond to antiviral therapy with the common drugs ganciclovir and acyclovir. ...

page 1 from 40